Fosinopril Sodium
Product Images NDC 50436-3138

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 50436-3138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

29914956-figure-01 (29914956 Figure 01)

Chemical structure of Fosinopril Sodium, shown as a detailed molecular diagram with rings, chains, and functional groups representing the active ingredient.*

FDA Label Image

29914956-figure-02 (29914956 Figure 02)

A table presenting clinical adverse events in placebo-controlled trials for hypertension comparing Fosinopril Sodium and placebo groups. It shows incidence and discontinuation percentages for cough, dizziness, and nausea/vomiting among participants.*

FDA Label Image

29914956-figure-03 (29914956 Figure 03)

A table presenting clinical adverse events observed in placebo-controlled trials for heart failure comparing Fosinopril Sodium (N=361) and placebo (N=373). It lists the incidence and discontinuation percentages for dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, and diarrhea for both groups.*

FDA Label Image

29914956-figure-04 (29914956 Figure 04)

A data table presenting the incidence and discontinuation rates of adverse events in subjects taking Fosinopril Sodium (N=361) compared to Placebo (N=373). The events listed include chest pain (non-cardiac), upper respiratory infection, orthostatic hypotension, subjective cardiac rhythm disturbance, and weakness with corresponding percentages for each group.*

FDA Label Image

Label Image (50436 3138)

Fosinopril Sodium 20 mg tablet bottle label from Unit Dose Services. The label shows the NDC 50436-3138-1 and contains 30 tablets. Manufacturer is listed as Camber. Storage instructions indicate to keep at 20-25°C (68-77°F) and out of reach of children. Multiple lot and expiration date placeholders are visible, as well as a QR code on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.